In addition to the potential Seed Funding sources, CRO preclinical scientists should also consider taking their studies to third party institutions. While these kinds of arrangements usually do not include seed money or investment, there are ongoing grants and contracts that the funding organization will offer. Interested parties can often negotiate for discounted payments based on the length of time that it takes for the preclinical study to come to market. CRO preclinical scientists should be aware of all of the details of any agreements before signing them.